DTE
47
2
ROST
49
2
AES
43
3
MET
66
5
NKE
31
-2
KO
57
2
EXPE
72
3
VFC
42
3
MRK
48
2
AIZ
56
6
HRL
48
-2
DE
60
12
LB
46
9
PCAR
42
3
HUM
36
-3
BK
74
5
HBAN
70
2
WM
68
-2
EBAY
57
-8
KMB
37
-2
DTE
47
2
ROST
49
2
AES
43
3
MET
66
5
NKE
31
-2
KO
57
2
EXPE
72
3
VFC
42
3
MRK
48
2
AIZ
56
6
HRL
48
-2
DE
60
12
LB
46
9
PCAR
42
3
HUM
36
-3
BK
74
5
HBAN
70
2
WM
68
-2
EBAY
57
-8
KMB
37
-2
Financhill
Back

Stoke Therapeutics Stock Predictions

The EXACT DAY Certain Stocks Soar - Year After Year

Find out now - completely free of charge.
Sell
45

STOK
Stoke Therapeutics

Last Price:
$11.12
Seasonality Move:
-9.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Tariffs Are Reshaping Markets

Grade any 3 stocks FREE to see if your portfolio is at risk.

Stoke Therapeutics Stock Forecast

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 7.7% based on the past 5 years of stock performance.
  • Stoke Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Stoke Therapeutics Stock Undervalued?
    The current Stoke Therapeutics [STOK] share price is $11.14. The Score for STOK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • STOK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Stoke Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 7.7% based on the past 5 years of stock performance.

Stoke Therapeutics Stock Rating

Sell
45
Stoke Therapeutics (STOK) is a Sell

Is Stoke Therapeutics overpriced?

  • Stoke Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Stoke Therapeutics Stock Price History

Is STOK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com

52-Week Data

52-Week High:
17.58
52-Week Low:
5.35

Prediction Charts

Market Cap:
608.2M
Price in USD:
11.14
Volume:
463.1K
Beta:
0.86

Technical Analysis

SMA50:
8.73
SMA100:
9.06
SMA200:
10.93
52-Wk Change:
-26.76%

Stock Predictions

  • Is Stoke Therapeutics stock public?
    Yes, Stoke Therapeutics is a publicly traded company.
  • What is the Stoke Therapeutics stock quote today?
    The Stoke Therapeutics stock price is 11.14 USD today.
  • How to buy Stoke Therapeutics stock online?
    You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-19 9.57 9.83 10.19 9.57
May-20 10.10 10.05 10.38 9.60
May-21 9.84 9.48 10.06 9.39
May-22 9.43 9.50 9.74 9.24
May-23 9.30 9.36 9.62 9.24
May-27 9.55 9.18 9.71 9.13
May-28 9.24 9.43 9.65 9.09
May-29 9.57 9.73 9.83 9.34
May-30 9.62 9.54 9.70 9.36
Jun-2 9.65 9.91 10.00 9.47
Jun-3 9.94 10.90 11.11 9.84
Jun-4 10.89 10.94 11.42 10.83
Jun-5 10.89 10.88 11.00 10.64
Jun-6 11.05 11.14 11.35 11.05

Stoke Therapeutics Earnings

Stoke Therapeutics Earnings Report: Per Share Stoke Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Stoke Therapeutics Forecast Revenue Growth

Stoke Therapeutics Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.16 per share, and a decrease next year of $2.87 per share.

* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.